NON-STATUTORY STOCK OPTION AGREEMENT FOR MEMBERS OF THE BOARD OF DIRECTORSNon-Statutory Stock Option Agreement • August 25th, 2023 • Biomerica Inc • In vitro & in vivo diagnostic substances • California
Contract Type FiledAugust 25th, 2023 Company Industry JurisdictionThis Stock Option Agreement (the “Agreement”) is made and entered into effective as of the date set forth on the Signature Page attached hereto by and between Biomerica, Inc., a Delaware corporation (the “Corporation”), and that person identified on the Signature Page below and attached hereto (the “Optionee”). This option is not intended to qualify and will not be treated as an “incentive stock option” with the meaning of Section 422 of the Internal Revenue Code (the “Code.”)
NON-STATUTORY STOCK OPTION AGREEMENTNon-Statutory Stock Option Agreement • October 14th, 2021 • Biomerica Inc • In vitro & in vivo diagnostic substances • California
Contract Type FiledOctober 14th, 2021 Company Industry JurisdictionThis Stock Option Agreement (the “Agreement”) is made and entered into effective as of the date set forth on the Signature Page attached hereto by and between Biomerica, Inc., a Delaware corporation (the “Corporation”), and that person identified on the Signature Page below and attached hereto (the “Optionee”). This option is not intended to qualify and will not be treated as an “incentive stock option” with the meaning of Section 422 of the Internal Revenue Code (the “Code.”)
NON-STATUTORY STOCK OPTION AGREEMENTNon-Statutory Stock Option Agreement • August 27th, 2021 • Biomerica Inc • In vitro & in vivo diagnostic substances • California
Contract Type FiledAugust 27th, 2021 Company Industry JurisdictionThis Stock Option Agreement (the “Agreement”) is made and entered into effective as of the date set forth on the Signature Page attached hereto by and between Biomerica, Inc., a Delaware corporation (the “Corporation”), and that person identified on the Signature Page below and attached hereto (the “Optionee”). This option is not intended to qualify and will not be treated as an “incentive stock option” with the meaning of Section 422 of the Internal Revenue Code (the “Code.”)